These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6431402)
41. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence. Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223 [TBL] [Abstract][Full Text] [Related]
42. First trimester diagnosis of Hunter syndrome on chorionic villi. Kleijer WJ; van Diggelen OP; Janse HC; Galjaard H; Dumez Y; Boué J Lancet; 1984 Aug; 2(8400):472. PubMed ID: 6147543 [No Abstract] [Full Text] [Related]
43. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). Voznyi YV; Keulemans JL; van Diggelen OP J Inherit Metab Dis; 2001 Nov; 24(6):675-80. PubMed ID: 11768586 [TBL] [Abstract][Full Text] [Related]
44. Prenatal tests for Sanfilippo disease type B in four pregnancies. Mossman J; Young EP; Patrick AD; Fensom AH; Ellis M; Benson PF; Der Kaloustian VM Prenat Diagn; 1983 Oct; 3(4):347-50. PubMed ID: 6419220 [TBL] [Abstract][Full Text] [Related]
45. Antenatal diagnosis of Hurler's syndrome. Henderson HE; Nelson MM S Afr Med J; 1977 Feb; 51(8):241-3. PubMed ID: 403618 [TBL] [Abstract][Full Text] [Related]
46. Heterozygote detection in Hunter syndrome. Zlotogora J; Bach G Am J Med Genet; 1984 Mar; 17(3):661-5. PubMed ID: 6424473 [TBL] [Abstract][Full Text] [Related]
47. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS). Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629 [TBL] [Abstract][Full Text] [Related]
48. Amniotic fluid secretor typing: validation for use in prenatal prediction of myotonic dystrophy. Teichler-Zallen D; Doherty RA Clin Genet; 1980 Oct; 18(4):257-67. PubMed ID: 6449321 [TBL] [Abstract][Full Text] [Related]
49. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II). Schröder W; Wulff K; Wehnert M; Seidlitz G; Herrmann FH Hum Mutat; 1994; 4(2):128-31. PubMed ID: 7981716 [TBL] [Abstract][Full Text] [Related]
50. The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome). Wraith JE; Cooper A; Thornley M; Wilson PJ; Nelson PV; Morris CP; Hopwood JJ Hum Genet; 1991 Jun; 87(2):205-6. PubMed ID: 1906048 [TBL] [Abstract][Full Text] [Related]
51. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid. Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246 [TBL] [Abstract][Full Text] [Related]
52. Gene diagnosis and carrier detection in Hunter syndrome by the iduronate-2-sulphatase cDNA probe. Gal A; Beck M; Sewell AC; Morris CP; Schwinger E; Hopwood JJ J Inherit Metab Dis; 1992; 15(3):342-6. PubMed ID: 1357230 [No Abstract] [Full Text] [Related]
53. [Clinical practice guideline for the management of Hunter syndrome. Hunter España working group]. Guillén-Navarro E; Blasco AJ; Gutierrez-Solana LG; Couce ML; Cancho-Candela R; Lázaro P; Med Clin (Barc); 2013 Nov; 141(10):453.e1-13. PubMed ID: 24060500 [No Abstract] [Full Text] [Related]
54. Tissue-specific mosaicism among fetuses with prenatally diagnosed diaphragmatic hernia. Donnenfeld AE; Campbell TJ; Byers J; Librizzi RJ; Weiner S Am J Obstet Gynecol; 1993 Oct; 169(4):1017-21. PubMed ID: 8238112 [TBL] [Abstract][Full Text] [Related]
55. Hunter syndrome: presence of material cross-reacting with antibodies against iduronate sulfatase. Daniele A; Di Natale P Hum Genet; 1987 Mar; 75(3):234-8. PubMed ID: 3104200 [TBL] [Abstract][Full Text] [Related]
56. Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands. Kleijer WJ; De Bruijn HW; Leschot NJ Br J Obstet Gynaecol; 1978 Jul; 85(7):512-7. PubMed ID: 79418 [TBL] [Abstract][Full Text] [Related]
57. Prenatal diagnosis of citrullinemia: elevated levels of citrulline in the amniotic fluid in the three affected pregnancies. Kleijer WJ; Blom W; Huijmans JG; Mooyman MC; Berger R; Niermeijer MF Prenat Diagn; 1984; 4(2):113-8. PubMed ID: 6739433 [TBL] [Abstract][Full Text] [Related]
58. A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots. Tolun AA; Graham C; Shi Q; Sista RS; Wang T; Eckhardt AE; Pamula VK; Millington DS; Bali DS Mol Genet Metab; 2012 Mar; 105(3):519-21. PubMed ID: 22227323 [TBL] [Abstract][Full Text] [Related]
59. Prenatal diagnosis of Maroteaux-Lamy syndrome. Van Dyke DL; Fluharty AL; Schafer IA; Shapiro LJ; Kihara H; Weiss L Am J Med Genet; 1981; 8(2):235-42. PubMed ID: 6792921 [TBL] [Abstract][Full Text] [Related]
60. Carcinoembryonic antigen (CEA) in normal and pre-eclamptic pregnancies (values in maternal blood, amniotic fluid and umbilical cord blood). Messinis IE; Milingos S; Lolis D; Diakomanolis E; Antoniou K; Chrysikou M; Kaskarelis D Eur J Obstet Gynecol Reprod Biol; 1980 Jun; 10(5):351-9. PubMed ID: 7190518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]